Department of Health and Human Services
200 Independence Avenue, S.W.
Washington
D.C.
20201
United States
Tel: 877-696-6775
Website: http://www.hhs.gov/
Email: hhsmail@os.dhhs.gov
234 articles with Department of Health and Human Services
-
New Health+™ Long COVID Report Translates Lived Experiences into Evidence-Based Recommendations
11/30/2022
The US Department of Health and Human Services and its Office of the Assistant Secretary of Health recently released a Health+ Long COVID Human-Centered Design Report produced by Coforma's Health+™ program.
-
HDT Bio Selected to Join BLUE KNIGHT™
11/7/2022
HDT Bio Corp. announced it has been selected to join Blue Knight, a collaboration between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response, a part of the U.S. Department of Health and Human Services.
-
HHS and the Cohen Foundation Name T2 Biosystems a Phase 1 Winner in LymeX Diagnostics Prize
11/7/2022
T2 Biosystems, Inc. announced that the U.S. Department of Health and Human Services and the Steven & Alexandra Cohen Foundation have selected T2 Biosystems as a Phase 1 winner in the LymeX Diagnostics Prize, a LymeX Innovation Accelerator prize competition to accelerate the development of Lyme disease diagnostics.
-
ABL Awarded $Multimillion Contract to Provide Manufacturing and Nonclinical Services to Support Development of Promising Therapeutics for the NINDS
11/4/2022
Advanced BioScience Laboratories announced it is one of three contractors awarded an Indefinite Delivery, Indefinite Quantity contract for "Manufacturing and Nonclinical Studies support for Development of Therapeutic Biotechnology Products for Neurological-related Disorders" by the NINDS of the NIH of the HHS.
-
Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
10/4/2022
Vir Biotechnology, Inc. announced that the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response, has awarded Vir a multi-year contract with the potential for up to $1 billion to advance the development of a full portfolio of innovative solutions to address influenza and potentially other infectious disease threats.
-
Centene Subsidiary Selected to Continue Serving Nebraska's Medicaid Managed Care Members
9/26/2022
Centene Corporation announced that its Nebraska subsidiary, Nebraska Total Care, has been awarded the Nebraska Department of Health and Human Services statewide Medicaid managed care contract.
-
Cases of monkeypox are growing at an alarming rate and Bavarian Nordic, the company that owns one of the two approved vaccines, may no longer be able to keep up.
-
American Nurses Association Calls for a Swift and Coordinated Response to Contain the Monkeypox Outbreak
8/5/2022
The US Department of Health and Human Services Secretary Xavier Becerra has declared the monkeypox outbreak to be a public health emergency.
-
The complaint alleges the agencies made an error under the Administrative Procedure Act, violating the Food Drug and Cosmetics Act by failing to approve Lumryz.
-
Sonic Healthcare USA authorized by HHS to perform testing for the Monkeypox Virus
7/5/2022
Sonic Healthcare USA was selected as one of five commercial laboratories authorized by the US Department of Health and Human Services through the Centers for Disease Control and Prevention to begin test validation using the CDC Non-variola Orthopoxvirus, high complexity NAAT molecular assay to identify Monkeypox.
-
Philips Signs Health Care Sector Pledge to Reduce Emissions as part of Department of Health and Human Services, White House Initiative
7/1/2022
Royal Philips announced the company has joined an initiative created by the Department of Health and Human Services, in partnership with the White House, to address climate action through the reduction of greenhouse gas emissions.
-
In an overwhelming vote of support, the U.S. House of Representatives approved the creation of a new department within the National Institutes of Health that is focused on biomedical innovation.
-
Bavarian Nordic announced the U.S. Biomedical Advanced Research and Development Authority has ordered an additional 500,000 doses of its monkeypox vaccine, Jynneos.
-
Calls for a reform of drug prices have become a regular occurrence, particularly in the midst of political campaigns. Yet a new report shows the median price of a new drug launched in 2021 was $180,000.
-
Monday, Moderna told a Delaware federal court that it was immune from patent-infringement charges over the COVID-19 vaccine because it supplied the vaccine for a U.S. government effort.
-
Celebrities' struggles with breast cancer are bringing new awareness to the importance of screening - particularly because new therapies like Radius Health's elacestrant are on the horizon.
-
Vir Biotechnology Scientists Named Winners of the BARDA and HHS-Sponsored Pediatric COVID-19 Data Challenge
4/6/2022
Vir Biotechnology, Inc. announced that a team of three company scientists were named one of the winners of the Pediatric COVID-19 Data Challenge, sponsored by the Biomedical Advanced Research and Development Authority and the U.S. Department of Health and Human Services.
-
BioSpace talked with Paul Mango, one of the key leaders of Operation Warp Speed, about the experience.
-
Venatorx Pharmaceuticals shared that its Phase III trial on the investigational treatment for complicated urinary tract infections in adults delivered positive outcomes.
-
The Committee for Medicinal Products for Human Use of the European Medicines Agency issued a negative trend vote on the company’s Marketing Authorization Application for Aduhelm.